633 related articles for article (PubMed ID: 24923364)
1. The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
Andreadou I; Iliodromitis EK; Rassaf T; Schulz R; Papapetropoulos A; Ferdinandy P
Br J Pharmacol; 2015 Mar; 172(6):1587-606. PubMed ID: 24923364
[TBL] [Abstract][Full Text] [Related]
2. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
Penna C; Granata R; Tocchetti CG; Gallo MP; Alloatti G; Pagliaro P
Curr Drug Targets; 2015; 16(8):843-67. PubMed ID: 25751010
[TBL] [Abstract][Full Text] [Related]
3. Preconditioning and postconditioning: underlying mechanisms and clinical application.
Hausenloy DJ; Yellon DM
Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
[TBL] [Abstract][Full Text] [Related]
4. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
5. Role of Hydrogen Sulfide in Myocardial Ischemia-Reperfusion Injury.
Zhang P; Yu Y; Wang P; Shen H; Ling X; Xue X; Yang Q; Zhang Y; Xiao J; Wang Z
J Cardiovasc Pharmacol; 2021 Feb; 77(2):130-141. PubMed ID: 33165141
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
Heusch G
Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
[TBL] [Abstract][Full Text] [Related]
7. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
Sivarajah A; McDonald MC; Thiemermann C
Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
[TBL] [Abstract][Full Text] [Related]
8. Remote ischaemic pre- and delayed postconditioning - similar degree of cardioprotection but distinct mechanisms.
Basalay M; Barsukevich V; Mastitskaya S; Mrochek A; Pernow J; Sjöquist PO; Ackland GL; Gourine AV; Gourine A
Exp Physiol; 2012 Aug; 97(8):908-17. PubMed ID: 22427438
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotection of pharmacological postconditioning on myocardial ischemia/reperfusion injury.
Wu Y; Liu H; Wang X
Life Sci; 2021 Jan; 264():118628. PubMed ID: 33131670
[TBL] [Abstract][Full Text] [Related]
10. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.
Ferdinandy P; Hausenloy DJ; Heusch G; Baxter GF; Schulz R
Pharmacol Rev; 2014 Oct; 66(4):1142-74. PubMed ID: 25261534
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective effects of hydrogen sulfide in attenuating myocardial ischemia‑reperfusion injury (Review).
Wu D; Gu Y; Zhu D
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34726247
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological pre- and post- conditioning agents: reperfusion-injury of the heart revisited.
Andreadou I; Iliodromitis EK; Koufaki M; Kremastinos DT
Mini Rev Med Chem; 2008 Aug; 8(9):952-9. PubMed ID: 18691153
[TBL] [Abstract][Full Text] [Related]
13. Signaling mediators modulated by cardioprotective interventions in healthy and diabetic myocardium with ischaemia-reperfusion injury.
Saeid F; Aniseh J; Reza B; Manouchehr VS
Eur J Prev Cardiol; 2018 Sep; 25(14):1463-1481. PubMed ID: 29442529
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.
Sivaraman V; Yellon DM
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):83-96. PubMed ID: 24038018
[TBL] [Abstract][Full Text] [Related]
15. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.
Heusch G; Rassaf T
Circ Res; 2016 Aug; 119(5):676-95. PubMed ID: 27539973
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial.
Eitel I; Stiermaier T; Rommel KP; Fuernau G; Sandri M; Mangner N; Linke A; Erbs S; Lurz P; Boudriot E; Mende M; Desch S; Schuler G; Thiele H
Eur Heart J; 2015 Nov; 36(44):3049-57. PubMed ID: 26385956
[TBL] [Abstract][Full Text] [Related]
17. The novel H
Testai L; Marino A; Piano I; Brancaleone V; Tomita K; Di Cesare Mannelli L; Martelli A; Citi V; Breschi MC; Levi R; Gargini C; Bucci M; Cirino G; Ghelardini C; Calderone V
Pharmacol Res; 2016 Nov; 113(Pt A):290-299. PubMed ID: 27616550
[TBL] [Abstract][Full Text] [Related]
18. Ischaemic conditioning and reperfusion injury.
Hausenloy DJ; Yellon DM
Nat Rev Cardiol; 2016 Apr; 13(4):193-209. PubMed ID: 26843289
[TBL] [Abstract][Full Text] [Related]
19. Endogenous cardioprotection by ischaemic postconditioning and remote conditioning.
Shi W; Vinten-Johansen J
Cardiovasc Res; 2012 May; 94(2):206-16. PubMed ID: 22323534
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide-mediated myocardial pre- and post-conditioning.
Predmore BL; Lefer DJ
Expert Rev Clin Pharmacol; 2011 Jan; 4(1):83-96. PubMed ID: 21373204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
